Ancora Advisors’s Veracyte VCYT Stock Holding History

Ancora Advisors’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-34	Closed	-$757	–	1923
2023 Q1	$757	Buy	+34	New	+$822	﹤0.01%	1661

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Ancora Advisors's VCYT Position: Q2 2023 in Review

Ancora Advisors sold out of Veracyte (VCYT) in Q2 2023, closing a stake of 34 shares — an estimated $757 sold.

Ancora Advisors first reported a position in VCYT in Q1 2023 and held it in 1 quarter. The position peaked at $757 in Q1 2023. 232 funds tracked by Wall St. Rank hold VCYT as of Q2 2023.

Ancora Advisors reported no remaining Veracyte position as of Q2 2023 after selling out during the quarter.
Ancora Advisors sold 34 Veracyte shares in Q2 2023, an estimated $757.
Ancora Advisors first reported a position in Veracyte in Q1 2023 and held it in 1 quarter.
Ancora Advisors's Veracyte position peaked at $757 in Q1 2023.
232 funds tracked by Wall St. Rank held Veracyte as of Q2 2023.

Based on Ancora Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.